Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Acta Diabetologica
Erschienen in: Acta Diabetologica 1/2011

01.03.2011 | Original Article

Study of coronary artery calcification risk in Egyptian adolescents with type-1 diabetes

verfasst von: M. Salem, I. Moneir, A. M. Adly, K. Esmat

Erschienen in: Acta Diabetologica | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The objective of the study is to assess coronary artery calcification (CAC) among adolescents with type-1 diabetes and to determine its relation with high-sensitivity C-reactive protein (hs-CRP), dyslipidaemia, glycaemic control and microvascular complications. The study included sixty patients with type-1 diabetes. Their ages ranged from 12 to 18 years and their diabetes duration ranged between 10 and 15 years. Patients were compared with 60 healthy subjects who served as controls. Clinical examination and laboratory investigations were done for evaluation of glycaemic control and presence of microvascular complications. Lipid profile, hs-CRP and multislice spiral computed tomography were done. Hs-CRP, total cholesterol, triglycerides and low-density lipoproteins levels were significantly higher in patients with diabetes compared to controls (P < 0.001). Twelve patients with diabetes (20%) had positive CAC. The mean calcium score was significantly higher in patients with diabetes compared to controls (P < 0.05). Smoking significantly affects CAC as 50% of smokers with diabetes had evidence of CAC compared to 9.1% of non-smokers with diabetes (P < 0.001). Fifty percent of patients with diabetes on angiotensin-converting enzyme inhibitor (ACEI) had evidence of CAC compared to 0% of patients without history of ACEI therapy (P < 0.001). Diabetics with CAC had significantly elder age, longer disease duration and higher mean glycosylated hemoglobin compared to diabetics without CAC (P < 0.05). Blood pressure percentiles, albumin creatinine ratio and serum lipids were significantly higher in patients with CAC compared to those without CAC (P < 0.001). All diabetics with severe retinopathy had positive CAC compared to 0% with normal Fundus (P < 0.001). All diabetics with overt nephropathy had positive CAC compared to 13.3% and 0% in micro- and normo-albuminuric patients (P < 0.001). Young patients with diabetes have evidence of CAC. Smoking, microvascular complications and dyslipidaemia might contribute to this risk.
Literatur
1.
Raggi P, Bellasi A, Ratti C (2005) Ischemia imaging and plaque imaging in diabetes complementary tools to improve cardiovascular risk management. Diabetes Care 28(11):2787–2794PubMedCrossRef
2.
Tarquini R, Lazzeri C, Pala L, Maria Rotella C, Franco Gensini G (2010) The diabetic cardiomyopathy. Acta Diabetol, online first, March, 2010
3.
Sicree R, Shaw J, Zimmet P (2006) Diabetes and impaired glucose tolerance. In: Gan D (ed) Diabetes atlas, 3rd edn. International Diabetes Federation, Brussels, pp 15–109
4.
Retnakaran R et al (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 55(6):1832–1839PubMedCrossRef
5.
Atkins RC, Zimmet P (2010) Diabetic kidney disease: act now or pay later. Acta Diabetol 47:1–4PubMedCrossRef
6.
Snell-Bergeon JK, Hokanson JE, Jensen L, MacKenzie T, Kinney G, Dabelea D, Eckel RH, Ehrlich J, Garg S, Rewers M (2003) Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 26(10):2923–2928PubMedCrossRef
7.
Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JC, Zinman B, for the DCCT/EDIC Research Group et al (2006) The effect of intensive glycemic treatment on coronary artery calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55(12):3556–3565PubMedCrossRef
8.
Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ (2003) Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study. Diabetes Care 26:1374–1379PubMedCrossRef
9.
Festa A, Haffner SM (2005) Inflammation and cardiovascular disease in patients with diabetes: lessons from the diabetes control and complications trial. Circulation 111:2414–2415PubMedCrossRef
10.
Haffner SM (2003) Statin therapy for the treatment of diabetic dyslipidemia. Diabetes Metab Res Rev 19(4):280–287PubMedCrossRef
11.
Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK et al (2005) Awareness and treatment of dyslipidemia in young adults with Type 1 diabetes. Diabetes Care 28(5):1051–1056PubMedCrossRef
12.
Cerbone AM, Macarone-Palmieri EG, Saldalamacchia EA, Coppola E, Di Minno E, Rivellese AA (2009) Diabetes, vascular complications and antiplatelet therapy: open problems. Acta Diabetol 46:253–261PubMedCrossRef
13.
Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I (2006) Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 19(5):462–466PubMedCrossRef
14.
Bar N, Erdogan M, Sezer E, Saygih F, Mert Özgönül A, Turgan N, Ersöz B (2009) Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria. Acta Diabetol 46:309–316CrossRef
15.
Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CDA (2002) C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 25(10):1813–1817PubMedCrossRef
16.
Nasir K, Budoff MJ, Post WS, Fishman EK, Mahesh M, Lima JA, Blumenthal RS (2003) Electron beam CT versus helical CT scans of coronary arteries: current utility and future directions. Am Heart J 146(6):949–977CrossRef
17.
Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jöckel KH, Erbel R et al (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf Recall Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 144(2):212–218PubMedCrossRef
18.
Lawlor DA, Whincup P, Emberson JR, Rees K, Walker M, Ebrahim S (2004) The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women’s Heart and Health Study and the British Regional Heart Study. Fam Pract 21(5):582–586PubMedCrossRef
19.
World Health Organization Expert Committee on Diabetes Mellitus (1980) Second Report, Technical Report Series. WHO, Geneva
20.
Diabetes Endocrine and Metabolic Unit and the National Research Center (2003) Cairo University. In: Collaboration with Wright State University. School of Medicine. Department of community health life span. Health research center. From a total sample size of 33189 girls and boys
21.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 pt 2):555–576CrossRef
22.
23.
Tabaei B, Al-Kassab A, Zawaski C, Herman W (2001) Does microalbuminuria predict diabetic nephropathy? Diabetic Care 24(9):1560–1566CrossRef
24.
Allain CC, Poom LS, Chan CSG et al (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20(4):470–475PubMed
25.
Wahlefeld AW (1974) Triglycerids determination after enzymatic hydrolysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Academic Press, New York, pp 1831–1835
26.
Harley CR, Gandhi SK, Heien H et al (2008) Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 9:669–676PubMedCrossRef
27.
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502PubMed
28.
Brian C, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17(6):1019–1025CrossRef
29.
Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ (2003) Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228(3):826–833PubMedCrossRef
30.
Schurgin S, Rich S, Mazzone T (2001) Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 24(2):335–338PubMedCrossRef
31.
Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH (2004) EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27(2):530–537PubMedCrossRef
32.
Rumberger JA, Sheedy PF II, Breen JF, Fitzpatrick LA, Schwartz RS (1996) Electron beam computed tomography and coronary artery disease: scanning for coronary artery calcification. Mayo Clin Proc 71:369–377PubMedCrossRef
33.
34.
Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ (2000) Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 49(9):1571–1578PubMedCrossRef
35.
Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY et al (2009) Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients. J Am Coll Cardiol Imag 2:339–349
36.
Starkman HS, Cable G, Hala V, Hecht H, Donnelly CM (2003) Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care 26(2):433–436PubMedCrossRef
37.
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Ceoautus Z, Kuulasmaa K, Keil U, for the WHO MONICA Project (2000) Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 355:688–700PubMedCrossRef
38.
Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of vascular disease in diabetes. Diabetologia 44(S2):S54–S64PubMedCrossRef
39.
Lee CD, Jacobs DR, Lee C-D, Schreiner PJ, Iribarren C, Arlene Hankinson A (2007) Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study 1–3. Am J Clin Nutr 86(1):48–54PubMed
40.
Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ (2007) Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 50(11):2280–2288PubMedCrossRef
41.
Bishop FK, Maahs DM, Snell-Bergeon JK, Ogden LG, Kinney GL, Rewers M (2009) Lifestyle risk factors for atherosclerosis in adults with type 1 diabetes. Diabetes Vasc Dis Res 6(4):269–275CrossRef
42.
International Society of Pediatric & Adolescent Diabetes. ISPAD (2007) Clinical practice consensus Guidelines for microvascular and macrovascular complications. Pediatr Diabetes 8(3):163–170CrossRef
43.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Power NR, Golden SH (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421–431PubMed
44.
Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S (2004) Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int 66(5):2022–2031PubMedCrossRef
45.
Oğuz A, Damcı T, Pehlivanoğlu S, Kültürsay H, Tokgözoğlu L, Şenocak M et al (2009) The impact of diabetes and coronary artery disease on mortality and morbidity in patients with hypertension. Türk Kardiyol Dern Arş Arch 37(4):221–225
46.
Maahs DM, Snell-Bergeon JK, Kinney GL, Wadwa RP, Garg S, Ogden LG, Rewers M (2007) ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification. J Diabetes Complicat 21(5):273–279PubMedCrossRef
47.
Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease the Atherosclerosis Risk in Communities Study. Diabetes Care 30(7):1742–1746PubMedCrossRef
48.
Klein BEK, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson ML, Moss SE, Reinke JO (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes. Arch Intern Med 164:1917–1924PubMedCrossRef
49.
Krishna P, Roopakola SM, Kumar KMP (2005) Dyslipidemia in type 1 diabetes mellitus in the young. Int J Diab Dev Ctries 25(4):110–112CrossRef
50.
Perez A, Wagner AM, Carreras G, Gimenez G, Sanchez-Quesada JL, Rigla M, Gomez-Gerique JA, Pou JM, de Leiva A (2000) Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Arch Intern Med 160(18):2756–2762PubMedCrossRef
51.
Petri A, Lusignan S, Williams J, Chan T, Majeed A (2006) Management of cardiovascular risk factors in people with diabetes in primary care: cross-sectional study. Public Health 120(7):654–663PubMedCrossRef
52.
Wong ND, Kawakubo M, LaBree L, Azen SP, Xiang M, Detrano R (2004) Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines. Am J Cardiol 94(4):431–436PubMedCrossRef
53.
Coulon J, Willems D, Dorchy H (2005) Increase in C-reactive protein plasma levels during diabetes in infants and young adults. Presse Med 34(2 Pt 1):89–93PubMedCrossRef
54.
Soedamah-Muthu SS, Stehouwer CD (2005) Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus: management strategies. Treat Endocrinol 4(2):75–86PubMedCrossRef
55.
Hosseinsabet A, Mohebbi A, Almasi A (2008) C-reactive protein and coronary calcium score. Association in coronary artery disease. Cardiol J 15(5):431–436
56.
Collins R, Armitage J, Parish S, Sleigh P, Peto R, the Heart Protection Study Collaborative Group (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016PubMedCrossRef
Metadaten
Titel
Study of coronary artery calcification risk in Egyptian adolescents with type-1 diabetes
verfasst von
M. Salem
I. Moneir
A. M. Adly
K. Esmat
Publikationsdatum
01.03.2011
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2011
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0214-4

Weitere Artikel der Ausgabe 1/2011

Acta Diabetologica 1/2011 Zur Ausgabe

Original Article

The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects

Original Article

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

Original Article

Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas

Original Article

The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography

Original Article

The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps

Review Article

The IGF system

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise